Buserelin - Pharm-SintezAlternative Names: Buserelin; Buserelin depo - Pharm-Sintez; Buserelin nasal spray - Pharm-Sintez; Buserelin-depo; Gonadotropin releasing harmone analogue - Pharm-Sintez
Latest Information Update: 29 Oct 2015
At a glance
- Originator Pharm-Sintez
- Class Antineoplastics; Hormones; Infertility therapies
- Mechanism of Action LHRH receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Breast cancer; Endometrial hyperplasia; Endometriosis; Infertility; Leiomyoma; Prostate cancer
Most Recent Events
- 15 Mar 2016 Biomarkers information updated